Literature DB >> 24999936

Resurrecting the 'yuppie vaccine'.

Cassandra Willyard.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24999936     DOI： 10.1038/nm0714-698

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

Review 1.  Approaches toward the directed design of a vaccine against Borrelia burgdorferi.

Authors:  Benjamin J Luft; John J Dunn; Catherine L Lawson
Journal:  J Infect Dis       Date:  2002-02-15       Impact factor: 5.226

2.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

Review 3.  Vaccines against Lyme disease: What happened and what lessons can we learn?

Authors:  Gregory A Poland
Journal:  Clin Infect Dis       Date:  2011-02       Impact factor: 9.079

4.  Lyme disease vaccination: safety first.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Lancet Infect Dis       Date:  2014-01       Impact factor: 25.071

5.  A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.

Authors:  L H Sigal; J M Zahradnik; P Lavin; S J Patella; G Bryant; R Haselby; E Hilton; M Kunkel; D Adler-Klein; T Doherty; J Evans; P J Molloy; A L Seidner; J R Sabetta; H J Simon; M S Klempner; J Mays; D Marks; S E Malawista
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

Review 6.  Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis.

Authors:  Allen C Steere; Elise E Drouin; Lisa J Glickstein
Journal:  Clin Infect Dis       Date:  2011-02       Impact factor: 9.079

7.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

Authors:  D M Gross; T Forsthuber; M Tary-Lehmann; C Etling; K Ito; Z A Nagy; J A Field; A C Steere; B T Huber
Journal:  Science       Date:  1998-07-31       Impact factor: 47.728

8.  Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

Authors:  Nina Wressnigg; Eva-Maria Pöllabauer; Gerald Aichinger; Daniel Portsmouth; Alexandra Löw-Baselli; Sandor Fritsch; Ian Livey; Brian A Crowe; Michael Schwendinger; Peter Brühl; Andreas Pilz; Thomas Dvorak; Julia Singer; Clair Firth; Benjamin Luft; Bernhard Schmitt; Markus Zeitlinger; Markus Müller; Herwig Kollaritsch; Maria Paulke-Korinek; Meral Esen; Peter G Kremsner; Hartmut J Ehrlich; P Noel Barrett
Journal:  Lancet Infect Dis       Date:  2013-05-10       Impact factor: 25.071

9.  Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.

Authors:  A C Steere; V K Sikand; F Meurice; D L Parenti; E Fikrig; R T Schoen; J Nowakowski; C H Schmid; S Laukamp; C Buscarino; D S Krause
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

10.  Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease.

Authors:  Christina M Small; Dharani K Ajithdoss; Aline Rodrigues Hoffmann; Waithaka Mwangi; Maria D Esteve-Gassent
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240
  10 in total
  5 in total

1.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

2.  Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.

Authors:  Amy J Ullmann; Theresa M Russell; Marc C Dolan; Martin Williams; Andrias Hojgaard; Zachary P Weiner; Barbara J B Johnson
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 3.  Recent Progress in Lyme Disease and Remaining Challenges.

Authors:  Jason R Bobe; Brandon L Jutras; Elizabeth J Horn; Monica E Embers; Allison Bailey; Robert L Moritz; Ying Zhang; Mark J Soloski; Richard S Ostfeld; Richard T Marconi; John Aucott; Avi Ma'ayan; Felicia Keesing; Kim Lewis; Choukri Ben Mamoun; Alison W Rebman; Mecaila E McClune; Edward B Breitschwerdt; Panga Jaipal Reddy; Ricardo Maggi; Frank Yang; Bennett Nemser; Aydogan Ozcan; Omai Garner; Dino Di Carlo; Zachary Ballard; Hyou-Arm Joung; Albert Garcia-Romeu; Roland R Griffiths; Nicole Baumgarth; Brian A Fallon
Journal:  Front Med (Lausanne)       Date:  2021-08-18

4.  Vaccination against Lyme disease: Are we ready for it?

Authors:  Patricia Kaaijk; Willem Luytjes
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 5.  Bacterial Lipoprotein Posttranslational Modifications. New Insights and Opportunities for Antibiotic and Vaccine Development.

Authors:  Luke Smithers; Samir Olatunji; Martin Caffrey
Journal:  Front Microbiol       Date:  2021-12-07       Impact factor: 5.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.